Colorectal cancer Posts on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

Is completion of irinotecan chemotherapy associated with better treatment response in locally advanced rectal cancer?

Is completion of irinotecan chemotherapy associated with better treatment response in locally advanced rectal cancer?

Posted by on Jul 5, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of high completion of irinotecan (Camptosar) chemotherapy before locally advanced rectal cancer surgery. Researchers suggested that the completion of irinotecan chemotherapy was associated with better tumor response in these patients. Some background Colorectal cancer is the third most...

Read More

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jul 1, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared two different chemotherapy treatments in metastatic colorectal cancer (mCRC; spread to other parts of the body). Researchers suggested that 24-hour infused irinotecan (Camptosar) plus oral S-1 (Teysuno) chemotherapy and bevacizumab (Avastin) is well tolerated and associated with improved outcomes. Some background...

Read More

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jun 25, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of two different chemotherapies in the treatment of advanced colorectal cancer (CRC). Researchers suggested that S1-based chemotherapy is a good option for the treatment of these patients. Some background CRC is one of the most common cancers worldwide. The standard treatment is surgery...

Read More

How does COVID-19 affect patients with cancer undergoing chemotherapy?

How does COVID-19 affect patients with cancer undergoing chemotherapy?

Posted by on Jun 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped. Some...

Read More

Dezocine reduces depression symptoms after colorectal cancer surgery

Dezocine reduces depression symptoms after colorectal cancer surgery

Posted by on Jun 14, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether dezocine (Dalgan) could relieve depression symptoms after CRC surgery. Researchers suggested that this drug reduces depression after surgery and improves sleep quality in patients with CRC. Some background CRC is one of the most common cancers worldwide. The standard treatment is surgery and chemotherapy....

Read More

The association between physical activity and long-term fatigue in colorectal cancer survivors

The association between physical activity and long-term fatigue in colorectal cancer survivors

Posted by on Jun 7, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of physical activity (PA) and long-term fatigue (tiredness) in patients with colorectal cancer. Researchers suggested that PA after the diagnosis is associated with less tiredness in these patients. Some background Colorectal cancer is the third most common cancer in men and the second in women...

Read More

Evaluating minimally invasive surgery for patients with rectal cancer

Evaluating minimally invasive surgery for patients with rectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of minimally invasive surgery in rectal cancer. Researchers suggested that less invasive surgery methods can result in better short-term outcomes in appropriately selected patients. Some background Colorectal cancer is the third most common cancer in the US. Rectal cancer comprises around 20% of...

Read More

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment with cytokine-induced killer cell (CIKC) immunotherapy and chemotherapy after surgery in colorectal cancer. Researchers suggested that this therapy improves treatment outcomes in patients with colorectal cancer. Some background Colorectal cancer is one of the most common...

Read More

The effectiveness and safety of regorafenib in older patients with advanced pretreated colorectal cancer

The effectiveness and safety of regorafenib in older patients with advanced pretreated colorectal cancer

Posted by on May 24, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of regorafenib (Stivarga) treatment in older patients with colorectal cancer (CRC). Researchers suggested that this treatment has similar effects in younger and older patients. Some background CRC is the third most common cancer worldwide. More than half are diagnosed in patients older...

Read More

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

Posted by on May 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of repeated cytoreductive surgery (CRS) and hyperthermic peritoneal chemotherapy (HIPEC) in patients with advanced colorectal cancer. Researchers suggested that repeated treatment improves the survival of patients with advanced colorectal cancer, without an increase in side effects. Some background...

Read More

Evaluating the effectiveness and safety of bevacizumab biosimilar in patients with metastatic colorectal cancer

Evaluating the effectiveness and safety of bevacizumab biosimilar in patients with metastatic colorectal cancer

Posted by on May 17, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of bevacizumab biosimilar (BE1040V) to the reference drug (Avastin) in the treatment of patients with metastatic colorectal cancer (mCRC). Researchers suggested that the effectiveness and safety of the biosimilar were similar to the reference drug bevacizumab. Some...

Read More

How common are late side effects after radiation treatment for rectal cancer?

Posted by on May 9, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the frequency of late gastrointestinal (GI) side effects after radiation therapy (RT) for rectal cancer. Researchers suggested that after the improvement of RT methods these side effects are less frequent and less severe. Some background Colorectal cancer is one of the most frequently diagnosed cancers in the...

Read More